Direct gamete uterine transfer in patients with tubal absence or occlusion

Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development. A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used. Patients studied included those with primary or secondary infertility, aged less than 38 y...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of assisted reproduction and genetics 1997, Vol.14 (1), p.35-38
Hauptverfasser: RANSOM, M. X, GARCIA, A. J, DOHERTY, K, SHELDEN, R, KEMMANN, E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 38
container_issue 1
container_start_page 35
container_title Journal of assisted reproduction and genetics
container_volume 14
creator RANSOM, M. X
GARCIA, A. J
DOHERTY, K
SHELDEN, R
KEMMANN, E
description Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development. A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used. Patients studied included those with primary or secondary infertility, aged less than 38 years, with no history of severe male-factor infertility, and with hysterosalpingogram- and laparoscopic-confirmed bilateral proximal tubal occlusion. Superovulation induction was accomplished with a combination of GnRH agonist and menotropins, with serum hormonal and sonographic monitoring. Within 24 hr prior to, and again at the time of, ovulatory hCG administration, progesterone (P4) was given. Sonographic-guided transvaginal retrieval was performed 35 hr after hCG. Between four and six oocytes were returned to the uterine cavity, admixed with sperm, immediately following retrieval. Luteal support consisted of daily P4 administration. Of the 20 patients recruited for the study, all completed the retrieval and transfer procedure. A total of four clinical pregnancies was achieved, with one early first-trimester loss, one late first-trimester loss (Trisomy 14), and two healthy term infants delivered. IVF of surplus oocytes demonstrated a 82.5% fertilization rate and 66.7% cleavage following cryopreservation. Human fertilization can be achieved through direct uterine transfer of gametes. Furthermore, administration of P4 prior to the ovulatory dose of hCG is compatible with in vitro or in vivo fertilization and implantation.
doi_str_mv 10.1007/BF02765750
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3454710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78809863</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-736ca15548291320bdf550e284255a72f7bd69771e4f36aea52f3866a929cbf93</originalsourceid><addsrcrecordid>eNpVkM9rFDEYhoNU1rZ68S7kUDwUVr8kk2TmUuivrUrBi57DN9kvbWR2Zk0yiv-9Kbus9ZQP3oc3Lw9jbwV8EAD249UKpDXaanjBjoW2ammVgqN6g26X0Jj2FTvJ-QcAdK1UC7boQFSiO2ZfbmIiX_gDbqgQnwulOBIvCcccKPE48i2WSGPJ_Hcsj7zMPQ4c-0yjJz4lPnk_zDlO42v2MuCQ6c3-PWXfV7ffrj8t77_efb6-vF_6BmSp04xHoXXTyk4oCf06aA0k20ZqjVYG269NZ62gJiiDhFoG1RqDnex8Hzp1yi52vdu539Da120JB7dNcYPpj5swuv-TMT66h-mXU41urIBa8H5fkKafM-XiNjF7GgYcaZqzs21bPRlVwfMd6NOUc6Jw-ESAezLv_pmv8Lvnsw7oXnXNz_Y5Zo9DqIZ9zAdMViHCGvUXXAWLAw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78809863</pqid></control><display><type>article</type><title>Direct gamete uterine transfer in patients with tubal absence or occlusion</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>PubMed Central</source><creator>RANSOM, M. X ; GARCIA, A. J ; DOHERTY, K ; SHELDEN, R ; KEMMANN, E</creator><creatorcontrib>RANSOM, M. X ; GARCIA, A. J ; DOHERTY, K ; SHELDEN, R ; KEMMANN, E</creatorcontrib><description>Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development. A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used. Patients studied included those with primary or secondary infertility, aged less than 38 years, with no history of severe male-factor infertility, and with hysterosalpingogram- and laparoscopic-confirmed bilateral proximal tubal occlusion. Superovulation induction was accomplished with a combination of GnRH agonist and menotropins, with serum hormonal and sonographic monitoring. Within 24 hr prior to, and again at the time of, ovulatory hCG administration, progesterone (P4) was given. Sonographic-guided transvaginal retrieval was performed 35 hr after hCG. Between four and six oocytes were returned to the uterine cavity, admixed with sperm, immediately following retrieval. Luteal support consisted of daily P4 administration. Of the 20 patients recruited for the study, all completed the retrieval and transfer procedure. A total of four clinical pregnancies was achieved, with one early first-trimester loss, one late first-trimester loss (Trisomy 14), and two healthy term infants delivered. IVF of surplus oocytes demonstrated a 82.5% fertilization rate and 66.7% cleavage following cryopreservation. Human fertilization can be achieved through direct uterine transfer of gametes. Furthermore, administration of P4 prior to the ovulatory dose of hCG is compatible with in vitro or in vivo fertilization and implantation.</description><identifier>ISSN: 1058-0468</identifier><identifier>EISSN: 1573-7330</identifier><identifier>DOI: 10.1007/BF02765750</identifier><identifier>PMID: 9013309</identifier><identifier>CODEN: JARGE4</identifier><language>eng</language><publisher>New York, NY: Kluwer/Plenum</publisher><subject>Adult ; Biological and medical sciences ; Birth control ; Chorionic Gonadotropin - therapeutic use ; Clinical Assisted Reproduction ; Cryopreservation ; Embryo Transfer - methods ; Fallopian Tube Diseases - therapy ; Fallopian Tubes - pathology ; Female ; Follicle Stimulating Hormone - therapeutic use ; Gynecology. Andrology. Obstetrics ; Humans ; Infertility, Female - therapy ; Male ; Medical sciences ; Oocyte Donation - methods ; Ovulation Induction ; Pregnancy ; Pregnancy Rate ; Progesterone - therapeutic use ; Spermatozoa ; Sterility. Assisted procreation ; Uterus - physiology</subject><ispartof>Journal of assisted reproduction and genetics, 1997, Vol.14 (1), p.35-38</ispartof><rights>1997 INIST-CNRS</rights><rights>Plenum Publishing Corporation 1997</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-736ca15548291320bdf550e284255a72f7bd69771e4f36aea52f3866a929cbf93</citedby><cites>FETCH-LOGICAL-c402t-736ca15548291320bdf550e284255a72f7bd69771e4f36aea52f3866a929cbf93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454710/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454710/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,27900,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2548176$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9013309$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RANSOM, M. X</creatorcontrib><creatorcontrib>GARCIA, A. J</creatorcontrib><creatorcontrib>DOHERTY, K</creatorcontrib><creatorcontrib>SHELDEN, R</creatorcontrib><creatorcontrib>KEMMANN, E</creatorcontrib><title>Direct gamete uterine transfer in patients with tubal absence or occlusion</title><title>Journal of assisted reproduction and genetics</title><addtitle>J Assist Reprod Genet</addtitle><description>Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development. A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used. Patients studied included those with primary or secondary infertility, aged less than 38 years, with no history of severe male-factor infertility, and with hysterosalpingogram- and laparoscopic-confirmed bilateral proximal tubal occlusion. Superovulation induction was accomplished with a combination of GnRH agonist and menotropins, with serum hormonal and sonographic monitoring. Within 24 hr prior to, and again at the time of, ovulatory hCG administration, progesterone (P4) was given. Sonographic-guided transvaginal retrieval was performed 35 hr after hCG. Between four and six oocytes were returned to the uterine cavity, admixed with sperm, immediately following retrieval. Luteal support consisted of daily P4 administration. Of the 20 patients recruited for the study, all completed the retrieval and transfer procedure. A total of four clinical pregnancies was achieved, with one early first-trimester loss, one late first-trimester loss (Trisomy 14), and two healthy term infants delivered. IVF of surplus oocytes demonstrated a 82.5% fertilization rate and 66.7% cleavage following cryopreservation. Human fertilization can be achieved through direct uterine transfer of gametes. Furthermore, administration of P4 prior to the ovulatory dose of hCG is compatible with in vitro or in vivo fertilization and implantation.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Birth control</subject><subject>Chorionic Gonadotropin - therapeutic use</subject><subject>Clinical Assisted Reproduction</subject><subject>Cryopreservation</subject><subject>Embryo Transfer - methods</subject><subject>Fallopian Tube Diseases - therapy</subject><subject>Fallopian Tubes - pathology</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - therapeutic use</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Infertility, Female - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Oocyte Donation - methods</subject><subject>Ovulation Induction</subject><subject>Pregnancy</subject><subject>Pregnancy Rate</subject><subject>Progesterone - therapeutic use</subject><subject>Spermatozoa</subject><subject>Sterility. Assisted procreation</subject><subject>Uterus - physiology</subject><issn>1058-0468</issn><issn>1573-7330</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM9rFDEYhoNU1rZ68S7kUDwUVr8kk2TmUuivrUrBi57DN9kvbWR2Zk0yiv-9Kbus9ZQP3oc3Lw9jbwV8EAD249UKpDXaanjBjoW2ammVgqN6g26X0Jj2FTvJ-QcAdK1UC7boQFSiO2ZfbmIiX_gDbqgQnwulOBIvCcccKPE48i2WSGPJ_Hcsj7zMPQ4c-0yjJz4lPnk_zDlO42v2MuCQ6c3-PWXfV7ffrj8t77_efb6-vF_6BmSp04xHoXXTyk4oCf06aA0k20ZqjVYG269NZ62gJiiDhFoG1RqDnex8Hzp1yi52vdu539Da120JB7dNcYPpj5swuv-TMT66h-mXU41urIBa8H5fkKafM-XiNjF7GgYcaZqzs21bPRlVwfMd6NOUc6Jw-ESAezLv_pmv8Lvnsw7oXnXNz_Y5Zo9DqIZ9zAdMViHCGvUXXAWLAw</recordid><startdate>1997</startdate><enddate>1997</enddate><creator>RANSOM, M. X</creator><creator>GARCIA, A. J</creator><creator>DOHERTY, K</creator><creator>SHELDEN, R</creator><creator>KEMMANN, E</creator><general>Kluwer/Plenum</general><general>Springer US</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>1997</creationdate><title>Direct gamete uterine transfer in patients with tubal absence or occlusion</title><author>RANSOM, M. X ; GARCIA, A. J ; DOHERTY, K ; SHELDEN, R ; KEMMANN, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-736ca15548291320bdf550e284255a72f7bd69771e4f36aea52f3866a929cbf93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Birth control</topic><topic>Chorionic Gonadotropin - therapeutic use</topic><topic>Clinical Assisted Reproduction</topic><topic>Cryopreservation</topic><topic>Embryo Transfer - methods</topic><topic>Fallopian Tube Diseases - therapy</topic><topic>Fallopian Tubes - pathology</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - therapeutic use</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Infertility, Female - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Oocyte Donation - methods</topic><topic>Ovulation Induction</topic><topic>Pregnancy</topic><topic>Pregnancy Rate</topic><topic>Progesterone - therapeutic use</topic><topic>Spermatozoa</topic><topic>Sterility. Assisted procreation</topic><topic>Uterus - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RANSOM, M. X</creatorcontrib><creatorcontrib>GARCIA, A. J</creatorcontrib><creatorcontrib>DOHERTY, K</creatorcontrib><creatorcontrib>SHELDEN, R</creatorcontrib><creatorcontrib>KEMMANN, E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of assisted reproduction and genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RANSOM, M. X</au><au>GARCIA, A. J</au><au>DOHERTY, K</au><au>SHELDEN, R</au><au>KEMMANN, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct gamete uterine transfer in patients with tubal absence or occlusion</atitle><jtitle>Journal of assisted reproduction and genetics</jtitle><addtitle>J Assist Reprod Genet</addtitle><date>1997</date><risdate>1997</risdate><volume>14</volume><issue>1</issue><spage>35</spage><epage>38</epage><pages>35-38</pages><issn>1058-0468</issn><eissn>1573-7330</eissn><coden>JARGE4</coden><abstract>Our aim was to examine the potential of the uterine cavity to affect fertilization and early embryo development. A prospective IRB-approved protocol for patients fulfilling study eligibility criteria was used. Patients studied included those with primary or secondary infertility, aged less than 38 years, with no history of severe male-factor infertility, and with hysterosalpingogram- and laparoscopic-confirmed bilateral proximal tubal occlusion. Superovulation induction was accomplished with a combination of GnRH agonist and menotropins, with serum hormonal and sonographic monitoring. Within 24 hr prior to, and again at the time of, ovulatory hCG administration, progesterone (P4) was given. Sonographic-guided transvaginal retrieval was performed 35 hr after hCG. Between four and six oocytes were returned to the uterine cavity, admixed with sperm, immediately following retrieval. Luteal support consisted of daily P4 administration. Of the 20 patients recruited for the study, all completed the retrieval and transfer procedure. A total of four clinical pregnancies was achieved, with one early first-trimester loss, one late first-trimester loss (Trisomy 14), and two healthy term infants delivered. IVF of surplus oocytes demonstrated a 82.5% fertilization rate and 66.7% cleavage following cryopreservation. Human fertilization can be achieved through direct uterine transfer of gametes. Furthermore, administration of P4 prior to the ovulatory dose of hCG is compatible with in vitro or in vivo fertilization and implantation.</abstract><cop>New York, NY</cop><pub>Kluwer/Plenum</pub><pmid>9013309</pmid><doi>10.1007/BF02765750</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1058-0468
ispartof Journal of assisted reproduction and genetics, 1997, Vol.14 (1), p.35-38
issn 1058-0468
1573-7330
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3454710
source MEDLINE; Springer Nature - Complete Springer Journals; PubMed Central
subjects Adult
Biological and medical sciences
Birth control
Chorionic Gonadotropin - therapeutic use
Clinical Assisted Reproduction
Cryopreservation
Embryo Transfer - methods
Fallopian Tube Diseases - therapy
Fallopian Tubes - pathology
Female
Follicle Stimulating Hormone - therapeutic use
Gynecology. Andrology. Obstetrics
Humans
Infertility, Female - therapy
Male
Medical sciences
Oocyte Donation - methods
Ovulation Induction
Pregnancy
Pregnancy Rate
Progesterone - therapeutic use
Spermatozoa
Sterility. Assisted procreation
Uterus - physiology
title Direct gamete uterine transfer in patients with tubal absence or occlusion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T17%3A23%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20gamete%20uterine%20transfer%20in%20patients%20with%20tubal%20absence%20or%20occlusion&rft.jtitle=Journal%20of%20assisted%20reproduction%20and%20genetics&rft.au=RANSOM,%20M.%20X&rft.date=1997&rft.volume=14&rft.issue=1&rft.spage=35&rft.epage=38&rft.pages=35-38&rft.issn=1058-0468&rft.eissn=1573-7330&rft.coden=JARGE4&rft_id=info:doi/10.1007/BF02765750&rft_dat=%3Cproquest_pubme%3E78809863%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78809863&rft_id=info:pmid/9013309&rfr_iscdi=true